The Auxological and Metabolic Consequences for Children Born Small for Gestational Age

被引:0
作者
Wayne Cutfield
Ahila Ayyavoo
机构
[1] University of Auckland,Department of Pediatric Endocrinology, Liggins Institute
[2] G. Kuppuswamy Naidu Memorial Hospital,Department of Pediatrics
来源
Indian Journal of Pediatrics | 2021年 / 88卷
关键词
SGA; Stature; Growth hormone; Metabolism;
D O I
暂无
中图分类号
学科分类号
摘要
'Small for gestational age' (SGA) is an auxological and not an etiological definition that characterizes children born small based upon low-birth-weight and/or birth-length criteria [≥ 2 standard deviations (SD) below the mean for gestational age]. Most SGA children exhibit catch-up growth into the normal range within 6 mo of age. Overall SGA children are 4 cm shorter than expected based upon midparental height and being born SGA is a common cause of adult short stature. Recombinant human growth hormone (rhGH) has been shown to improve adult height by 0.9 SDs and is a safe treatment. Surprisingly, a higher rhGH dose (67 μgm/kg/d) did not lead to a greater adult height than a conventional dose (33 μgm/kg/d). At least 85% of SGA children treated through childhood with rhGH achieve a height within the normal adult range. Other long-term consequences for children born SGA include insulin resistance, abdominal adiposity, dyslipidemia, type 2 diabetes mellitus, and metabolic syndrome. Cross-sectional studies have found reduced insulin sensitivity in the neonatal, childhood, and young adult periods. Increased abdominal fat has been shown in preschool SGA children and is more evident in young adults. Increased adiposity markedly accentuates reduction in insulin sensitivity. Many SGA children have suffered from in utero nutritional restriction that leads to long-term growth restriction and adverse metabolic sequelae.
引用
收藏
页码:1235 / 1240
页数:5
相关论文
共 242 条
[1]  
Lee PA(2003)International small for gestational age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001 Pediatrics 111 1253-1261
[2]  
Chernausek SD(1995)Growth in full-term small-for-gestational-age infants: from birth to final height Pediatr Res 38 733-739
[3]  
Hokken-Koelega AC(1972)The small-for-date infant I Later growth patterns Pediatrics 49 671-681
[4]  
Czernichow P(1994)Natural growth in children born small for gestational age with and without catch-up growth Acta Paediatr Suppl 399 64-70
[5]  
Karlberg J(1987)Growth of 519 small for gestational age infants during the first two years of life Acta Paediatr Scand 76 636-646
[6]  
Albertsson-Wikland K(2001)Definition of fetal growth restriction according to constitutional growth potential Biol Neonate 80 277-285
[7]  
Fitzhardinge PM(2003)Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre-and postnatal growth in two European small for gestational age populations J Clin Endocrinol Metab 88 4805-4810
[8]  
Steven EM(2005)Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome Nat Genet 37 1003-1007
[9]  
Albertsson-Wikland K(2002)Chromosome 7p disruptions in Silver Russell syndrome: delineating an imprinted candidate gene region Hum Genet 111 376-387
[10]  
Karlberg J(2006)(Epi)mutations in 11p15 significantly contribute to Silver-Russell syndrome: but are they generally involved in growth retardation? Eur J Med Genet 49 414-418